New award for naproxen tablets with radha pharmaceuticals, INC. Period of performance is 8/1/2026-7/31/2027.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79726D0029
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 21% complete
IDV ceiling
$12,991,005.00
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Radha Pharmaceuticals Inc. for Naproxen Tablets with a ceiling value of $12,991,005 on August 1, 2026. Radha Pharmaceuticals is a minority-owned manufacturer and distributor of generic pharmaceuticals.

The contract covers a period of performance from August 1, 2026 through July 31, 2027 (base year) with four pre-priced one-year option periods, providing up to five years of potential supply. No set-aside was applied; the procurement was fully open and competed.

The solicitation, RFP 36E79726R0011, sought Naproxen Tablets in three strengths (250MG, 375MG, and 500MG) in both 100-bottle and 500-bottle package configurations to support the VA's Pharmaceutical Prime Vendor Programs serving the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The total estimated annual requirement is approximately 153,363 bottles across six line items. NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals) apply.

The contract incorporates firm-fixed pricing and requires the contractor to provide an uninterrupted source of supply. A modification was issued to incorporate Section 5 of Executive Order 14398, Clause 52.222-90, addressing diversity, equity, and inclusion discrimination compliance (April 2026 version).

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Modification to incorporate section 5 of EO 14398, clause 52.222-90, addressing DEI discrimination by federal contractors (APR 2026), into the contract. $0
Original award $0

Quick answers

Who was awarded contract 36E79726D0029?

36E79726D0029 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on August 1, 2026.

How much is contract 36E79726D0029 worth?

36E79726D0029's own ceiling is $12,991,005.

Who can order from contract 36E79726D0029?

36E79726D0029 is a single award indefinite delivery contract.

Was contract 36E79726D0029 competed?

The extent of competition for 36E79726D0029 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV